For many of us, Covid-19 feels like a chapter we've closed – along with the days of PCR tests, mask mandates and daily case updates. But while life may feel back to normal, the virus hasn't completely vanished. In fact, new variants continue to quietly circulate.
One of the latest to appear on the radar is NB.1.8.1 – a name that you may have seen pop up in headlines and on social media feeds this week.
This newly emerging sub-variant hasn't triggered widespread concern, but it has caught the attention of scientists and health officials.
The UK Health Security Agency (UKHSA) announced this week that NB.1.8.1 has so far only been detected in small numbers within the UK, but added that international data indicates that the sub-variant is steadily accounting for a growing share of global Covid-19 cases.
We consulted some GPs to find out exactly what sets the NB.1.8.1 Covid variant apart from the rest. Is it more contagious, more immune-evasive, or simply another step in Covid's slow evolution? Here's what they know so far…
What is the new NB.1.8.1 Covid variant and where has it come from?
"The NB.1.8.1 variant, also referred to as Nimbus, is a new strain of the Covid-19 virus that has emerged due to mutations in its genetic material," says Dr Naveed Asif, GP at The London General Practice.
It's a sub-variant of Omicron, says Dr Chun Tang, GP at Pall Mall Medical.
"Variants like this pop up when the virus mutates, which is normal for viruses, especially ones that spread widely," explains Tang. "NB.1.8.1 was first picked up in early 2025 and has since been detected in several countries, including the UK, China and US. It's got some new mutations that scientists are keeping a close eye on."
How is it different from previous variants?
"NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity," says Tang. "That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it."
However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Asif.
"Its spread has been identified in around 22 countries," says Asif. "The World Health Organization (WHO) assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease."
How is it spreading?
"It's spreading in the usual way, person to person, mainly through respiratory droplets when people cough, sneeze or even just talk closely," says Tang. "Like other variants, it can hang around in the air in poorly ventilated spaces."
What symptoms should people look out for?
"Common symptoms of the NB.1.8.1 variant include severe sore throat (described as a "razor blade sensation"), fatigue, mild cough, fever, muscle aches and congestion," says Asif. "However, symptoms can vary widely so vigilance is key."
What are the treatment options?
"Treatment for Nimbus generally aligns with that for other Covid-19 variants," says Asif. "Most individuals will recover at home with rest, hydration, and over-the-counter medications for symptom management.
"For those with severe symptoms or high-risk complications, antiviral medications or monoclonal antibody treatments may be recommended. Always consult your GP for personalised advice."
How can you avoid getting the new variant?
"Make sure everyone's up to date with their Covid-19 jabs, especially boosters," recommends Tang. "Wash your hands regularly, keep rooms well ventilated, and consider popping a mask on in busy places or if you're around people who are more vulnerable.
"If someone in the house is feeling poorly, try to keep some distance and clean shared surfaces regularly."
When should you see a GP about this?
"Seek medical advice if you experience Covid-19 symptoms, especially if they worsen or if you have underlying health conditions that increase your risk," advises Asif. "Additionally, consult your GP if you've been in close contact with someone who has tested positive for the NB.1.8.1 variant or if you have health concerns."
News
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
